These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37862035)

  • 1. Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs.
    Mattingly TJ; Ben-Umeh KC; Bai G; Anderson GF
    JAMA Health Forum; 2023 Oct; 4(10):e233660. PubMed ID: 37862035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
    J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018.
    Van Nuys K; Ribero R; Ryan M; Sood N
    JAMA Health Forum; 2021 Nov; 2(11):e213409. PubMed ID: 35977268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
    Johnsrud M; Lawson KA; Shepherd MD
    J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of Retail Pricing of Generic Urologic Medications in a Major US Metropolitan Area.
    Xu PJ; Barnes JM; Choe EM; Syed JR; Siddiqui SA
    Urology; 2019 Mar; 125():29-33. PubMed ID: 30170089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
    Carroll NV
    J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?
    Kanavos P; Taylor D
    Curr Med Res Opin; 2007 Oct; 23(10):2467-76. PubMed ID: 17764613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gross profits of Canadian pharmacies: A changing policy regime.
    Thanh NX; Jacobs P; Husereau D
    Healthc Manage Forum; 2020 Sep; 33(5):228-232. PubMed ID: 32552055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drug costs and the generic dispensing ratio.
    Liberman JN; Roebuck MC
    J Manag Care Pharm; 2010 Sep; 16(7):502-6. PubMed ID: 20726679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy.
    Mattingly TJ; Hyman DA; Bai G
    JAMA Health Forum; 2023 Nov; 4(11):e233804. PubMed ID: 37921745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges for Managed Care from 340B Contract Pharmacies.
    Fein AJ
    J Manag Care Spec Pharm; 2016 Mar; 22(3):197-203. PubMed ID: 27003548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    Pauly NJ; Talbert JC; Brown J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spread: pilot study of an undocumented source of pharmacy benefit manager revenue.
    Garis RI; Clark BE
    J Am Pharm Assoc (2003); 2004; 44(1):15-21. PubMed ID: 14965148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of European pharmaceutical price regulation on generic price competition: a review.
    Puig-Junoy J
    Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do generics offer significant savings to the UK National Health Service?
    Kanavos P
    Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
    Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
    Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
    Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
    J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neurologist's Guide to Drug Pricing in the United States.
    Nair KV; Santoro JD
    Continuum (Minneap Minn); 2024 Aug; 30(4):1259-1271. PubMed ID: 39088295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.